🇺🇸 FDA
Patent

US 12275937

Stereospecific linkages in RNA editing oligonucleotides

granted A61PA61P3/00

Quick answer

US patent 12275937 (Stereospecific linkages in RNA editing oligonucleotides) held by ProQR Therapeutics II B.V. expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ProQR Therapeutics II B.V.
Grant date
Tue Apr 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P3/00